‘Ozempic Santa’: Musk Reveals His Use Of Mounjaro In Latest Weight-Loss Drug Endorsement [Forbes]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Forbes
support for weight-loss drugs as he has pushed for making them more accessible to the general public. Musk published the post Wednesday. (Allison Robbert/Pool via AP) AFP or licensors Key Facts Musk posted a photo of himself dressed as Santa without the holiday figure's traditionally plump look, captioning the post, “Ozempic Santa.” Musk elaborated in a follow-up post he is technically using the Eli Lilly weight-loss drug Mounjaro over Novo Nordisk's Ozempic, “but that doesn't have the same ring to it.” The post comes two weeks after Musk said on X “nothing would do more to improve the health, lifespan and quality of life for Americans” than making glucagon-like peptide-1 receptor (GLP-1) medications like Ozempic and Mounjaro “ super low cost to the public. ” GLP-1 medications are considered prescription drugs and can cost Americans around $1,000 per month if they are uninsured. Get Forbes Breaking News Text Alerts : We're launching text message alerts so you'll always
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Why Eli Lilly (LLY) Dipped More Than Broader Market Today [Yahoo! Finance]Yahoo! Finance
- THE SKIN OF COLOR SOCIETY (SOCS) WRAPS ITS 20TH ANNIVERSARY YEAR WITH LANDMARK ACHIEVEMENTS AND AN EXPANDED SLATE OF INITIATIVES ADVANCING KNOWLEDGE, EXCELLENCE, AND HEALTH EQUITY [Yahoo! Finance]Yahoo! Finance
- Will This Major Pharmaceutical Stock Announce a Stock Split in 2025? [Yahoo! Finance]Yahoo! Finance
- PQE Group Joins Project-COMFORT to Advance Patient-Centric Blood Collection and Diagnostics [Yahoo! Finance]Yahoo! Finance
- Is Eli Lilly Stock a Buy? [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 10/30/24 - Miss
LLY
Sec Filings
- 12/17/24 - Form 4
- 12/17/24 - Form 4
- 12/17/24 - Form 4
- LLY's page on the SEC website